http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-916558-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e737b999245afb461a9a9e552e8f3a1e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
filingDate 1960-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb9c75dfdcc0f27064b556a0c693e30b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ea1b1f894bcaccf97bf2b47e592a945
publicationDate 1963-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-916558-A
titleOfInvention Enol ethers of 4-substituted 3-oxo-í~-steroids
abstract The invention comprises steroids having apart from possible additional unsaturated linkages and substituents at the 11-, 16- and 17-positions the formula <FORM:0916558/IV (b)/1> (wherein R is an alkyl or cycloalkyl radical of at most 7 carbon atoms, R1 is methyl or chlorine and R11 is hydrogen or methyl) and their preparation by reacting the corresponding D 4-3-ketones with the appropriate alcohol ROH or with an orthoester thereof in the presence of a catalytic quantity of hydrogen ions. Conveniently a trialkylorthoformate HC(OR)3 is used, in the presence of a catalytic quantity of the corresponding alcohol and an acid catalyst such as sulphuric, toluene-psulphonic, perchloric or hydrochloric acid, in an inert solvent. Alternatively the alcohol ROH may be used alone in the presence of an azeotropic carrier such as iso-octane. In a third method ethyl orthoformate is used and the pre-formed enol ethyl ether is then reacted with the desired alcohol. The process may be applied to steroids of the androstane, pregnane or spirostane series which may additionally contain unsaturated linkages at positions such as 9-11, 16-17, 17-20 and 20-21, hydroxy or acyloxy groups at positions 11, 16, 17, 20 or 21, oxo groups at positions 11, 17 and 20, alkyl groups of up to 4 carbon atoms at positions such as 11, 16, 17 and 21, ethynyl groups and substituted ethynyl groups of up to 4 carbon atoms at position 17, methylene groups at positions such as 11 and 16, halogen atoms at positions such as 11, 16, 17 and 21, isopropylidenedioxy groups at position 16-17 in 20 - oxo - pregnanes and bis-methylenedioxy groups at position 17a ,20:20,21. Detailed examples are provided. In the Provisional Specification R is defined as an alkyl or alicyclic radical of at most 7 carbon atoms, and reference is made to starting materials containing, in addition to the groups and unsaturated linkages detailed above, unsaturated linkages at positions 6-7, 7-8, 11-12 and 15-16, alkyl groups at positions 1, 2 and 7 and halogen atoms at position 9. Specification 888,165 is referred to.
priorityDate 1960-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439513
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID94144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552855
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415862011
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411280324
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20164361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53925414

Total number of triples: 42.